A study on the role of rivaroxaban in management of venous thromboembolism
Background: Over 50 years the research work all over the world was concerning to find out a novel oral heparin to avoid the side effects of conventional anticoagulants as warfarin which requires changes in diet and lifestyle, regular checkup, and has a risk of severe hemorrhage. Rivaroxaban offers s...
Main Authors: | Mohmed Abdalwahab, Yousef Mansour, Ayman El-Dib |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-10-01
|
Series: | Egyptian Journal of Chest Disease and Tuberculosis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0422763815300029 |
Similar Items
-
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
by: Shohei Migita, et al.
Published: (2023-08-01) -
Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry
by: Victoria Speed, et al.
Published: (2021-12-01) -
Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01) -
Fatigue after initiating rivaroxaban for venous thromboembolism
by: Tina Margrethe Karlsvik, et al.
Published: (2020-05-01) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021-10-01)